Cat. No.: DIA-0243311
Product Information | |
---|---|
Formula | C141H185N35O40S2.xC2HF3O2 |
Molecular Weight | 3074.33 (free acid) |
Target | Angiotensin-converting Enzyme (ACE) |
Product Description | DX600 TFA is a selective ACE2 specific inhibitor (KD: 1.3 nM), and does not cross-react with ACE. DX600 TFA exacerbates diabetes-induced cardiovascular dysfunction and the increase in cardiac and renal NOX activity. |
Format & Storage | |
---|---|
Format | Solid |
Color | White to off-white |
Purity | 99.94% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | In solvent: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
Solubility Overview | Soluble in water |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.